Cibinqo 50 mg (Abrocitinib TABLET) 50 MG

CIBINQO 50 MG tablets are a medication used to manage moderate to severe plaque psoriasis. This oral treatment is designed to help reduce inflammation and improve skin condition. Learn more about CIBINQO 50 MG uses and effects.

Strength

50 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CIBINQO 50 MG tablets are primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. This medication works by targeting specific pathways in the immune system to reduce inflammation and improve skin condition. People often ask, 'What is CIBINQO used for?' and the answer lies in its ability to manage symptoms of psoriasis effectively.

Side Effects

Common effects of CIBINQO 50 MG tablets may include nausea, diarrhea, and upper respiratory tract infections. Some users might experience headaches or fatigue. These effects can vary from person to person, and it's important to consult a healthcare provider for personalized advice.

Precautions & Warnings

CIBINQO 50 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration guidelines. Patients with a history of infections or immune system disorders should discuss their medical history with a healthcare provider before starting this medication.

Avoid Interactions

CIBINQO 50 MG tablets may interact with certain medications, including those that affect the immune system or other oral treatments. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.

Frequently Asked Questions

CIBINQO is used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

CIBINQO 50 MG tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, upper respiratory tract infections, headaches, and fatigue.

CIBINQO may interact with other medications. Consult your healthcare provider before combining it with other treatments.

CIBINQO is not suitable for everyone, especially those with a history of infections or immune system disorders. Always consult a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.